This inventor holds 23 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Neurodegenerative Compounds. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2014-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridgeshire, GB (2018)
- Cambridge, GB (2014 - 2021)
Company Filing History:
Years Active: 2014-2025
Areas of Expertise:
Title: The Innovative Contributions of William John Farnaby
Introduction
William John Farnaby is a prominent inventor based in Cambridge, GB, known for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 23 patents, Farnaby has made impactful advancements in the treatment of various medical conditions, specifically through his work in neurodegenerative diseases and other therapeutic areas.
Latest Patents
Farnaby's cutting-edge research has resulted in several noteworthy patents. One of his latest inventions is focused on pyridazinone compounds, which serve as DAAO inhibitors. This invention presents compounds of formula (I) and pharmaceutically acceptable salts, detailing processes for their preparation, formulations, and therapeutic applications. In addition, he has developed a patent for 1-arylcarbonyl-4-oxy-piperidine compounds, which are valuable for the prophylaxis and treatment of neurodegenerative diseases. The specification outlines a novel compound or its salts, with each component meticulously defined for effective use.
Career Highlights
Currently, William John Farnaby is associated with Takeda Pharmaceutical Company Limited, where he continues to leverage his expertise in drug development and innovation. His persistent efforts in pharmaceutical research have not only led to significant patents but have also contributed to advancements in treatment methodologies for various health conditions.
Collaborations
Throughout his career, Farnaby has collaborated with esteemed colleagues, including Tatsuki Koike and Masato Yoshikawa. These partnerships have fostered a dynamic environment for innovation and have propelled the progress of their collective research endeavors.
Conclusion
William John Farnaby exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, characterized by a series of impactful patents, reflect his dedication to advancing medical science. Through his work at Takeda Pharmaceutical Company Limited and collaboration with notable coworkers, Farnaby continues to pave the way for future advancements in therapeutic inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile